Submitted by medscape9178 in health
Treatment with crizanlizumab didn't improve survival or days free of cardiopulmonary support in patients hospitalized with COVID-19 in a randomized study.
Submitted by medscape9178 in health
Treatment with crizanlizumab didn't improve survival or days free of cardiopulmonary support in patients hospitalized with COVID-19 in a randomized study.